New methods based on surfaces or beads have allowed measurement of properties of single DNA molecules in very accurate ways. Theoretical coarse grained models have been developed to understand the behavior of single stranded and double stranded DNA. These models have been shown to be accurate and relatively simple for very short systems of 6-8 base pairs near surfaces. Comparatively less is known about the influence of a surface on the secondary structures of longer molecules important to many technologies. Surface fields due to either applied potentials and/or dielectric boundaries are not in current surface mounted coarse grained models. To gain insight into longer and surface mounted sequences we parameterized a discretized worm-like chain model. Each link is considered a sphere of 6 base pairs in length for dsDNA, and 1.5 bases for ssDNA (requiring an always even number of spheres). For this demonstration of the model, the chain is tethered to a surface by a fixed length, non-interacting 0.536 nm linker. Configurational sampling was achieved via Monte-Carlo simulation. Our model successfully reproduces end to end distance averages from experimental results, in agreement with polymer theory and all atom simulations. Our average tilt results are also in agreement with all atom simulations for the case of dense systems.
Accurate modeling and design of protein-ligand
interactions have broad applications in cell, synthetic
biology and drug discovery but remain challenging without
experimental protein structures. Here we developed an
integrated protein homology modeling-ligand docking-protein
design approach that reconstructs protein-ligand binding
sites from homolog protein structures in the presence of
protein-bound ligand poses to capture conformational
selection and induced fit modes of ligand binding. In
structure modeling tests, we blindly predicted near-atomic
accuracy ligand conformations bound to G protein-coupled
receptors (GPCRs) that were rarely identified by traditional
approaches. We also quantitatively predicted the binding
selectivity of diverse ligands to
structurally-uncharacterized GPCRs. We then applied the
technique to design functional human dopamine receptors with
novel ligand binding selectivity. Most blindly predicted
ligand binding specificities closely agreed with
experimental validations. Our method should prove useful in
ligand discovery approaches and in reprogramming the ligand
binding profile of membrane receptors that remain difficult
to crystallize.
Summary
Solvent molecules interact intimately with proteins and can profoundly regulate their structure and function. However, accurately and efficiently modeling protein solvation effects at the molecular level has been challenging. Here, we present a method that improves the atomic-level modeling of soluble and membrane protein structures and binding by efficiently predicting de novo protein-solvent molecule interactions. The method predicted with unprecedented accuracy buried water molecule positions, solvated protein conformations, and challenging mutational effects on protein binding. When applied to homology modeling, solvent-bound membrane protein structures, pockets, and cavities were recapitulated with near-atomic precision even from distant homologs. Blindly refined atomic-level structures of evolutionary distant G protein-coupled receptors imply strikingly different functional roles of buried solvent between receptor classes. The method should prove useful for refining low-resolution protein structures, accurately modeling drug binding sites in structurally-uncharacterized receptors, and designing solvent-mediated protein catalysis, recognition, ligand binding, and membrane protein signaling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.